ClinicalTrials.Veeva

Menu

Comparing Use of Radiographs Versus Patient Empowerment (CURVE)

R

Radboud University Medical Center

Status

Enrolling

Conditions

Adolescent Idiopathic Scoliosis

Treatments

Other: Standard follow-up
Other: Patient-empowered follow up

Study type

Interventional

Funder types

Other

Identifiers

NCT05379127
80-87600-98-19048

Details and patient eligibility

About

Objective: To evaluate the (cost-)effectiveness of a new patient-empowered follow up (FU) protocol in patients with Adolescent idiopathic Scoliosis (AIS) that is based on patient-reported outcome measures (PROMs), self-assessment tools and physical examination, which is compared to standard FU care by: 1) Effect evaluation, 2) Economic evaluation, 3) Implementation (process) evaluation.

Study design: A multicentre pragmatic randomized trial design with two arms, combined with a patient preference cohort for each arm (partially randomized preference trial [PRPT]).

Study population: A total of 812 AIS patients (age 10-18 years) treated by the Dutch AIS Consortium, representing the scoliosis treatment centres in the Netherlands, will be included.

Three subgroups of AIS patients are distinguished, which are monitored over two years:

  1. Pre-treatment group: adolescents with curve 10-25° (n=132 per arm; total n=264)
  2. Post-brace treatment group (n=122 per arm; total n=244)
  3. Post-surgery group (n=152 per arm; total n=304)

Intervention: The new patient-empowered FU protocol (PE-FU) is based on PROMs, self-assessment tools and clinical assessment including physical examination. The protocol aims to detect curve progression or postoperative complications based on these patient-based and clinical parameters to substitute the need to obtain routine x-rays. X-rays will only be taken when progression or postoperative complications are suspected in the pre- and post-intervention groups based on predefined criteria. The standard FU protocol consists of routine full-spine radiographs and routine clinical evaluations.

Enrollment

812 estimated patients

Sex

All

Ages

10 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with adolescent idiopathic scoliosis (AIS).
  • Age: 10-18 years old.
  • Patients scheduled for follow up in one of the participating centres.
  • Understanding of the Dutch language.
  • Signed informed consent.
  • Biplanar (Posterior-Anterior [PA] and Lateral) full-spine x-rays within the last 3 months.

Specifically for the pre-treatment group:

  • Girls aged ≤14 years (i.e. 10-14 years) and boys <16 years (i.e. 10-15 years). These patients still have generally 2 years of remaining skeletal growth. Patients above this age with a curve below 25 degrees have a limited risk for progression
  • Girls: pre-menarche up to 6 months post-menarche (to estimate end of growth)
  • A primary coronal curve of 10-25 degree.

Specifically for the post-brace group:

  • Patients aged 12-18 years
  • Within 3 months after termination of brace treatment
  • Minimum of 6 months of brace treatment

Specifically for the post-surgery group:

• Patients aged 12-18 years

Exclusion criteria

  • Patients with juvenile or infantile idiopathic scoliosis with the diagnosis of onset under the age of 10.
  • Patients who are undergoing brace treatment. These patients are not included because of the need to monitor brace therapy with radiographs.
  • Patients who have undergone previous spinal surgery and are undergoing revision surgery.
  • Skeletally mature patients.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

812 participants in 2 patient groups

Standard follow-up
Other group
Description:
standard care during follow-up
Treatment:
Other: Standard follow-up
Patient-empowered follow-up
Experimental group
Treatment:
Other: Patient-empowered follow up

Trial contacts and locations

23

Loading...

Central trial contact

Jurre Baetsen, MSc; Miranda L van Hooff, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems